Earth Science Tech amends acquisition terms with two firms

Published 11/03/2025, 21:48
Earth Science Tech amends acquisition terms with two firms

Earth Science Tech, Inc. (OTC:ETST), a Florida-based biotechnology company specializing in pharmaceutical preparations with a market capitalization of $39.35 million and impressive revenue growth of 409% in the last twelve months, has revised the terms of its acquisition agreement with Las Villas Healthcare, LLC and Doconsultations.com, LLC, according to a recent 8-K filing with the U.S. Securities and Exchange Commission. According to InvestingPro analysis, the company currently appears undervalued based on its Fair Value estimates.

The amendment, announced today, reduces the total purchase price from $400,000 to $200,000. The initial agreement, dated January 30, 2025, had already seen the targets receive a payment of $50,000. Following this amendment, Earth Science Tech will pay the remaining $150,000 at the closing of the transaction. Despite recent stock volatility, with shares down 10.34% in the past week, the company maintains strong fundamentals with a healthy gross profit margin of 71.86%.

This closing is expected to follow the completion of a ninety-day due diligence period, which is currently in progress. The reduction in the purchase price represents a significant change in the terms of the acquisition, which may have implications for both Earth Science Tech and the companies it is acquiring.

The original filing indicates that the company’s strategic move to acquire these entities is part of its broader efforts to expand its operations within the healthcare sector. The details of the amendment were made public in line with regulatory requirements and to inform shareholders and potential investors of the changes in the acquisition’s financial terms.

The information in this article is based on a press release statement.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.